newsNovel nanocarrier enables targeted treatment of gliomas in vivo1 March 2021 | By Hannah Balfour (European Pharmaceutical Review)The new nanoparticle formulation enabled researchers to selectively target glioma cells with Dp44mT, a potent chelator and promising anti-cancer therapeutic, for the first time.
newsNovel antibiotic shows promise in Phase II C. difficile study20 November 2020 | By Hannah Balfour (European Pharmaceutical Review)Ibezapolstat cured all 10 patients of their Clostridioides difficile infections and prevented recurrence for at least 30 days.